Polycystic Kidney Disease (eBook)
XIII, 273 Seiten
Springer New York (Verlag)
978-1-4939-7784-0 (ISBN)
This comprehensive guide to polycystic kidney disease captures the growing knowledge of this common, potentially-fatal and hereditary disease. The first two sections of the book provide an overview of PKD gene structures, mutations and pathophysiologic mechanisms. This is followed by chapters focused on PKD's clinical features, including renal and extrarenal manifestations, and appropriate management of patients. The final section covers current clinical trials and emerging therapies in PKD. Authored by experts in the field, this book provides the clinician and researcher with critical information on basic and translational science and clinical approaches in one concise resource.
John J. Bissler, MD
Federal Express Chair of Excellence, Professor and Chief, Division of Nephrology, Department of Pediatrics, Director of the Tuberous Sclerosis Center of Excellence at Le Bonheur Children's Hospital, Medical Director of Nephrology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center
University of Tennessee Health Science Center
Children's Foundation Research Center
Memphis, TN
Benjamin D. Cowley, Jr., M.D., F.A.C.P., F.A.S.N.
Professor of Medicine
Chief, Nephrology & Hypertension
John Gammill Professor in Polycystic Kidney Disease
University of Oklahoma Health Sciences Center
Oklahoma City, OK
This comprehensive guide to polycystic kidney disease captures the growing knowledge of this common, potentially-fatal and hereditary disease. The first two sections of the book provide an overview of PKD gene structures, mutations and pathophysiologic mechanisms. This is followed by chapters focused on PKD's clinical features, including renal and extrarenal manifestations, and appropriate management of patients. The final section covers current clinical trials and emerging therapies in PKD. Authored by experts in the field, this book provides the clinician and researcher with critical information on basic and translational science and clinical approaches in one concise resource.
John J. Bissler, MD Federal Express Chair of Excellence, Professor and Chief, Division of Nephrology, Department of Pediatrics, Director of the Tuberous Sclerosis Center of Excellence at Le Bonheur Children’s Hospital, Medical Director of Nephrology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center University of Tennessee Health Science Center Children’s Foundation Research Center Memphis, TN Benjamin D. Cowley, Jr., M.D., F.A.C.P., F.A.S.N.Professor of MedicineChief, Nephrology & HypertensionJohn Gammill Professor in Polycystic Kidney DiseaseUniversity of Oklahoma Health Sciences Center Oklahoma City, OK
PART 1. POLYCYSTIC KIDNEY DISEASE GENES & PROTEINS1. Classical Polycystic Kidney Disease (PKD): Gene Structures and Mutations and Protein Structures and Functions 2. Bardet-Biedl Syndrome 3. Cystic Kidney Diseases Associated with Increased Cancer Risk: Tuberous Sclerosis Complex, Von Hippel Lindau, and Birt Hogg Dubé PART 2. POLYCYCSTIC KIDNEY DISEASE: MECHANISMS OF DISEASE 4. Aberrant Cellular Pathways in PKD 5. Cilia and Polycystic Kidney Disease 6. The Role of Inflammation and Fibrosis in Cystic Kidney Disease PART 3. CLINICAL FEATURES 7. Imaging-based Diagnosis of Autosomal Dominant Polycystic Kidney Disease 8. Renal Structural Involvement in Autosomal Dominant Polycystic Kidney Disease: Cyst Growth and Total Kidney Volume: Lessons from the Consortium for Radiologic Imaging of Polycystic Kidney Disease (CRISP) 9. Renal Complications: Pain, Infection and Nephrolithiasis 10. ADPKD Extrarenal Manifestations: Polycystic Liver Disease 11. Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease PART 4. CLINICAL TRIALS AND EMERGING THERAPIES 12. Role of Renin- Angiotensin- Aldosterone System Inhibition in Autosomal Dominant Polycystic Kidney Disease 13. Vasopressin Receptor Antagonism 14. End-stage Renal Disease in Patients with Autosomal Dominant Polycystic Kidney Disease 15. Polycystic Kidney Disease: Translating Mechanisms into Therapy Management of ADPKD Today
| Erscheint lt. Verlag | 24.5.2018 |
|---|---|
| Zusatzinfo | XIII, 273 p. 62 illus., 42 illus. in color. |
| Verlagsort | New York |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Nephrologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
| Schlagworte | Clinical Features of PKD • Emergicing Therapies for PKD • end stage renal disease • Genetic Disease • Pathophysiologic Mechanisms of PKD • Polycystic Kidney Disease |
| ISBN-10 | 1-4939-7784-9 / 1493977849 |
| ISBN-13 | 978-1-4939-7784-0 / 9781493977840 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 10,5 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
